Electrocardiographic Features of Patients with COVID-19: An Updated Review
- PMID: 35221086
- PMCID: PMC8556537
- DOI: 10.1016/j.ccep.2021.10.006
Electrocardiographic Features of Patients with COVID-19: An Updated Review
Abstract
Numerous systemic manifestations, including cardiac involvement in the form of myocardial infarction, myocarditis, and electrocardiographic changes, have been associated with COVID-19..In this review, the authors describe the electrocardiographic features that have been reported to date in patients affected by this disease and their possible underlying mechanisms.
Keywords: COVID 19; ECG; Electrocardiography.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr L. Di Biase is a consultant for Stereotaxis, Biosense Webster, Boston Scientific, and Abbott Medical and has received speaker honoraria/travel support from Medtronic, Atricure, Bristol Meyers Squibb, Pfizer, and Biotronik. Dr A. Natale is a consultant for Biosense Webster, Stereotaxis, and Abbott and has received speaker honoraria/travel support from Medtronic, Atricure, Biotronik, and Janssen. Remaining authors report no conflict of interest.
Figures




References
-
- Bitencourt L., Pedrosa A.L., Soares de Brito S.B.C., et al. COVID-19 and renal diseases: an update. Curr Drug Targets. 2021;22(1):52–67. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical